Horizon Hospice & Palliative Care Medicare Approved Location: 833 West Chicago Avenue, Chicago, Illinois 60622 Phone: (312) 733-2233 |
Unity Hospice Of Chicagoland, Llc Medicare Approved Location: 600 W Cermak Rd Suite 3d, Chicago, Illinois 60616 Phone: (312) 949-1188 |
Vitas Corporation Medicare Approved Location: 1340 South Damen Avenue, Ste 200, Chicago, Illinois 60608 Phone: (312) 997-7200 |
Hospice Of Illinois Medicare Approved Location: 5061 N Pulaski Rd, Chicago, Illinois 60630 Phone: (847) 296-2811 |
Maximum Hospice And Palliative Care Medicare Approved Location: 8327 S South Chicago Avenue, Ste B, Chicago, Illinois 60617 Phone: (312) 379-0096 |
Loving Hands Hospice Medicare Approved Location: 6535 North Olmstead Avenue, Suite 150, Chicago, Illinois 60631 Phone: (773) 775-1536 |
Comfort Hospice And Palliative Care Llc Medicare Approved Location: 8750 W Bryn Mawr Avenue Ste 460, Chicago, Illinois 60631 Phone: (847) 983-8257 |
Hospice Of Greater Chicago Llc Medicare Approved Location: 1727 S Indiana Ave Suite G2, Chicago, Illinois 60616 Phone: (903) 824-3067 |
Oasis Hospice & Palliative Care Inc Medicare Approved Location: 11700 S Western Avenue Suite 13-14, Chicago, Illinois 60643 Phone: (773) 941-4838 |
News Archive
New research from the University of Utah in collaboration with the Utah Department of Health (UDOH) shows that the presence or absence of intellectual disability (ID) and autism spectrum disorders (ASD) varies with risk factors such as gender, parental age, maternal ethnicity, and maternal level of education.
Novartis announced today that the results of the MEASURE 1 and MEASURE 2 Phase III studies for Cosentyx® (secukinumab) in ankylosing spondylitis (AS) were published in The New England Journal of Medicine (NEJM). These pivotal studies demonstrated significant clinical improvements with Cosentyx versus placebo in reducing the signs and symptoms of active AS – a long-term, painful and debilitating inflammation of the spine.
Federal drug agents and one of the nation's biggest drug distributors are heading for a legal showdown that will test the government's strategy of going after larger corporations to fight rampant prescription drug abuse.
Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn't receive the drug, according to a new study by a team from the University of Michigan.
Cancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm that detects worsening symptoms based on objective changes in patient behavior, according to a new study from the University of Pittsburgh and UPMC Hillman Cancer Center.
› Verified 9 days ago